Stockscreener 앱 받기
78.50
1.23%
-0.98
시간 외 거래:
78.50
전일 마감가:
$79.48
열려 있는:
$79.51
하루 거래량:
626.53K
Relative Volume:
0.79
시가총액:
$4.31B
수익:
$1.43B
순이익/손실:
$107.13M
주가수익비율:
40.52
EPS:
1.9372
순현금흐름:
$161.04M
1주 성능:
+0.15%
1개월 성능:
+12.14%
6개월 성능:
+24.45%
1년 성능:
+77.00%
1일 변동 폭
$77.89
$80.57
1주일 범위
$77.45
$80.95
52주 변동 폭
$41.02
$80.95
Livanova Plc Stock (LIVN) Company Profile
명칭
Livanova Plc
전화
4402033250662
주소
20 EASTBOURNE TERRACE, LONDON
Compare LIVN vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
78.50 | 4.38B | 1.43B | 107.13M | 161.04M | 1.9372 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-19 | 개시 | KeyBanc Capital Markets | Overweight |
| 2025-10-01 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-05-20 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-02-26 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | 개시 | Goldman | Buy |
| 2024-09-17 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | 재확인 | Needham | Buy |
| 2024-02-20 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-09-06 | 개시 | HSBC Securities | Hold |
| 2023-07-19 | 개시 | Robert W. Baird | Neutral |
| 2023-04-14 | 개시 | Mizuho | Neutral |
| 2022-12-21 | 개시 | Barclays | Equal Weight |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-02-24 | 업그레이드 | UBS | Neutral → Buy |
| 2021-12-03 | 개시 | Goldman | Buy |
| 2021-08-20 | 재확인 | Needham | Buy |
| 2021-07-20 | 업그레이드 | Needham | Hold → Buy |
| 2021-03-03 | 다운그레이드 | Berenberg | Buy → Hold |
| 2021-01-05 | 다운그레이드 | Needham | Buy → Hold |
| 2020-09-02 | 개시 | Robert W. Baird | Outperform |
| 2020-06-26 | 재확인 | Needham | Buy |
| 2019-10-30 | 재확인 | Needham | Buy |
| 2019-02-28 | 재확인 | Needham | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-08-02 | 재확인 | Needham | Buy |
| 2018-06-08 | 개시 | Stifel | Buy |
| 2018-05-31 | 재확인 | Needham | Buy |
| 2018-02-28 | 재확인 | Needham | Buy |
모두보기
Livanova Plc 주식(LIVN)의 최신 뉴스
Jette Nygaard-Andersen joins LivaNova board as a new director - MSN
Is LivaNova’s (LIVN) Boardroom Refresh Quietly Reframing Its Long-Term Risk and Strategy Playbook? - simplywall.st
Jette Nygaard-Andersen named director of LivaNova board - Medical Buyer
LivaNova (LIVN) Stock Valuation Check After Strong Recent Shareholder Returns - Yahoo Finance
LivaNova to present at Goldman Sachs Global Healthcare Conference in June - MSN
LivaNova adds Jette Nygaard-Andersen to board of directors - Investing.com UK
LivaNova adds Jette Nygaard-Andersen to board of directors By Investing.com - Investing.com Canada
Jette Nygaard-Andersen Joins LivaNova Board as a New Director - The Joplin Globe
LivaNova Stock: My Targets Hold, Maintaining My Rating For 2H26 (NASDAQ:LIVN) - Seeking Alpha
LivaNova stock hits 52-week high at 76.92 USD - Investing.com
LivaNova stock hits 52-week high at 76.92 USD By Investing.com - Investing.com Canada
LivaNova PLC at Goldman Sachs Healthcare Conference Transcript - GuruFocus
LivaNova PLC (LIVN) Stock Up 3.4% but GF Value Says Overvalued -- GF Score: 77/100 - GuruFocus
LIVN: Improved VNS reimbursement and manufacturing scale drive growth, with OSA and new launches ahead - TradingView
LivaNova appoints Anne Liddy as chief legal officer - MSN
LivaNova beats estimates but shares fall 2% on guidance concerns - Investing.com
Earnings call transcript: LivaNova PLC beats Q1 2026 estimates, shares rise - Investing.com
LivaNova names Anne Liddy as chief legal officer By Investing.com - Investing.com Australia
LivaNova names Anne Liddy as chief legal officer - Investing.com
LivaNova Appoints Anne Liddy as Chief Legal Officer - The Joplin Globe
LivaNova Q1 2026 slides: double-digit growth drives guidance raise - Investing.com
LivaNova beats estimates but shares fall 2% on guidance concerns By Investing.com - Investing.com Nigeria
LivaNova PLC (LIVN) Shares Surge 3.4% -- What GF Score of 78 Tel - GuruFocus
LivaNova PLC (LIVN) Shares Surge 3.4% -- What GF Score of 78 Tells Investors - GuruFocus
Did LivaNova's (LIVN) New Cardiopulmonary Chief from Philips Just Redefine Its Leadership Bench? - Sahm
Insider Sell Alert: Francesco Bianchi Sells Shares of LivaNova P - GuruFocus
LivaNova (LIVN) director Bianchi sells 1,800 shares in open-market trade - Stock Titan
LivaNova (LIVN) files Form 144; Merrill Lynch listed for proposed sale - Stock Titan
LivaNova appoints Stefano Folli to lead its cardiopulmonary business unit - MSN
LivaNova Plc Hits New 52-Week High at USD 74.28 - MarketsMojo
LivaNova names Stefano Folli as president, CP - Medical Buyer
Why (LIVN) Price Action Is Critical for Tactical Trading - Stock Traders Daily
LIVN Technical Analysis & Stock Price Forecast - Intellectia AI
LivaNova (LIVN) Edges Higher as Stock Tests Key Resistance at $77.52Dark Pool Prints - Newser
Paradice Investment Management LLC's LivaNova PLC(LIVN) Holding History - GuruFocus
LivaNova names Stefano Folli as cardiopulmonary president - Investing.com UK
LivaNova appoints Franco Poletti as President, Cardiopulmonary - TipRanks
LivaNova names Stefano Folli as cardiopulmonary president By Investing.com - Investing.com South Africa
LivaNova names Stefano Folli to head cardiopulmonary unit - StreetInsider
LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit - Business Wire
LivaNova PLC stock (US5356991077): cardiac device specialist in focus after regulatory update and ea - AD HOC NEWS
LivaNova’s SWOT analysis: medical device stock eyes growth plan By Investing.com - Investing.com Nigeria
LivaNova’s SWOT analysis: medical device stock eyes growth plan - Investing.com
Livanova Plc (LIVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Livanova Plc 주식 (LIVN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Bianchi Francesco | Director |
May 26 '26 |
Sale |
75.75 |
1,800 |
136,350 |
7,228 |
2.43%
자본화:
|
볼륨(24시간):